H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015
CBO Score
$220 million
Documentation
Date of Report
Thu July 23rd, 2015
CBO Report Details
Legislation Details
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
114th Congress
Sponsor: Rep. Christopher Smith — R — NJ
Introduced 06/18/15
Passed House: 12/16/15
Passed Senate: 12/16/15
Latest Action: 12/18/15
This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.) The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. (Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised. HHS must determine whether to include peripheral blood stem cells ...